Castle Biosciences (CSTL) stock Forecast for 2021 – 2025

Castle Biosciences (CSTL) stock Forecast for 2022 – 2026

Last update: March 23, 2023 (09:14)

Sector: Healthcare

The share price of Castle Biosciences, Inc. (CSTL) now

What analysts predict: $45.88
52-week High/Low: $47.27 / $15.58

50/200 Day Moving Average: $24.98 / $24.85

This figure corresponds to the Average Price over the previous 50/200 days. For Castle Biosciences stocks, the 50-day moving average is the resistance level today.

For Castle Biosciences stocks, the 200-day moving average is the resistance level today.

Are you interested in Castle Biosciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Castle Biosciences stock price in 2023, 2024, 2025, 2026, 2027. How much will one Castle Biosciences share be worth in 2023 - 2027?

When should I take profit in Castle Biosciences stock? When should I record a loss on Castle Biosciences stock? What are analysts' forecasts for Castle Biosciences stock? What is the future of Castle Biosciences stock? We forecast Castle Biosciences stock performance using neural networks based on historical data on Castle Biosciences stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Castle Biosciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Castle Biosciences shares. This happens once a day.




Historical and forecast chart of Castle Biosciences stock

The chart below shows the historical price of Castle Biosciences stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Castle Biosciences stock price can be found in the table below.

Long-term forecasts by years.

Castle Biosciences daily forecast for a month

Date Target Pes. Opt. Vol., %
Mar 25 21.60 21.14 22.24 5.19
Mar 26 21.86 21.22 22.38 5.44
Mar 27 21.54 21.22 21.81 2.80
Mar 28 21.11 20.60 21.45 4.14
Mar 29 21.86 21.49 22.51 4.76
Mar 30 21.96 21.75 22.39 2.91
Mar 31 22.19 21.93 22.71 3.56
Apr 01 22.01 21.75 22.35 2.75
Apr 02 21.62 21.13 21.99 4.05
Apr 03 21.53 21.08 21.76 3.23
Apr 04 20.98 20.43 21.48 5.18
Apr 05 21.03 20.47 21.70 6.04
Apr 06 21.81 21.39 22.16 3.63
Apr 07 21.61 21.37 22.26 4.17
Apr 08 22.05 21.38 22.32 4.37
Apr 09 22.46 22.24 22.65 1.82
Apr 10 22.73 22.53 23.38 3.79
Apr 11 22.51 22.25 22.96 3.20
Apr 12 22.63 22.25 23.05 3.62
Apr 13 22.97 22.69 23.51 3.65
Apr 14 23.19 22.45 23.68 5.50
Apr 15 22.85 22.44 23.15 3.18
Apr 16 23.21 22.59 23.74 5.09
Apr 17 23.93 23.22 24.42 5.15
Apr 18 23.63 23.17 23.94 3.30
Apr 19 23.50 22.75 24.07 5.83
Apr 20 23.82 23.61 24.15 2.30
Apr 21 23.96 23.33 24.68 5.79
Apr 22 23.48 22.94 23.76 3.56
Apr 23 23.77 23.30 24.16 3.67

Castle Biosciences Daily Price Targets


Castle Biosciences Stock Forecast 03-25-2023.

Forecast target price for 03-25-2023: $21.60.
Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 4.934%.
Pessimistic target level: 21.14
Optimistic target level: 22.24

Castle Biosciences Stock Forecast 03-26-2023.

Forecast target price for 03-26-2023: $21.86.
Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 5.158%.
Pessimistic target level: 21.22
Optimistic target level: 22.38

Castle Biosciences Stock Forecast 03-27-2023.

Forecast target price for 03-27-2023: $21.54.
Negative dynamics for Castle Biosciences shares will prevail with possible volatility of 2.725%.
Pessimistic target level: 21.22
Optimistic target level: 21.81

Castle Biosciences Stock Forecast 03-28-2023.

Forecast target price for 03-28-2023: $21.11.
Negative dynamics for Castle Biosciences shares will prevail with possible volatility of 3.975%.
Pessimistic target level: 20.60
Optimistic target level: 21.45

Castle Biosciences Stock Forecast 03-29-2023.

Forecast target price for 03-29-2023: $21.86.
Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 4.543%.
Pessimistic target level: 21.49
Optimistic target level: 22.51

Castle Biosciences Stock Forecast 03-30-2023.

Forecast target price for 03-30-2023: $21.96.
Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 2.826%.
Pessimistic target level: 21.75
Optimistic target level: 22.39

CSTL (CSTL) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Apr. 24.77 22.24 25.64 13.26
May. 27.75 26.78 30.36 11.78
Jun. 29.19 25.92 30.62 15.35
Jul. 25.60 23.02 26.49 13.12
Aug. 26.10 25.26 28.80 12.31
Sep. 28.62 27.50 30.26 9.14
Oct. 29.06 25.80 31.13 17.12
Nov. 29.95 27.77 31.38 11.49
Dec. 29.41 26.12 32.00 18.40

Castle Biosciences forecast for this year


Castle Biosciences Stock Prediction for Apr 2023

An uptrend is forecast for this month with an optimal target price of $24.7723. Pessimistic: $22.24. Optimistic: $25.64


Castle Biosciences Stock Prediction for May 2023

An uptrend is forecast for this month with an optimal target price of $27.7549. Pessimistic: $26.78. Optimistic: $30.36


Castle Biosciences Stock Prediction for Jun 2023

An uptrend is forecast for this month with an optimal target price of $29.1926. Pessimistic: $25.92. Optimistic: $30.62


Castle Biosciences Stock Prediction for Jul 2023

An downtrend is forecast for this month with an optimal target price of $25.5961. Pessimistic: $23.02. Optimistic: $26.49


Castle Biosciences Stock Prediction for Aug 2023

An uptrend is forecast for this month with an optimal target price of $26.0977. Pessimistic: $25.26. Optimistic: $28.80


Castle Biosciences Stock Prediction for Sep 2023

An uptrend is forecast for this month with an optimal target price of $28.6188. Pessimistic: $27.50. Optimistic: $30.26


Castle Biosciences Stock Prediction for Oct 2023

An uptrend is forecast for this month with an optimal target price of $29.0595. Pessimistic: $25.80. Optimistic: $31.13


Castle Biosciences Stock Prediction for Nov 2023

An uptrend is forecast for this month with an optimal target price of $29.9545. Pessimistic: $27.77. Optimistic: $31.38


Castle Biosciences Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $29.4094. Pessimistic: $26.12. Optimistic: $32.00



Castle Biosciences (CSTL) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 26.28 24.29 28.89 15.92
Feb 26.21 23.68 28.30 16.34
Mar 26.17 25.03 27.97 10.48
Apr 28.70 27.37 31.15 12.12
May 32.64 29.85 36.24 17.65
Jun 33.18 31.56 35.41 10.89
Jul 35.04 31.46 38.03 17.28
Aug 36.71 34.04 39.74 14.35
Sep 41.39 39.24 42.95 8.63
Oct 45.67 43.63 48.87 10.73
Nov 48.74 43.83 54.20 19.14
Dec 45.54 42.09 47.07 10.57

Castle Biosciences (CSTL) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 42.60 40.04 46.96 14.73
Feb 36.82 34.55 40.63 14.97
Mar 35.79 31.78 38.79 18.08
Apr 39.95 37.65 42.80 12.02
May 37.49 35.96 39.69 9.39
Jun 42.26 38.06 45.81 16.92
Jul 41.85 38.33 45.77 16.26
Aug 42.02 37.61 43.26 13.06
Sep 37.37 33.61 41.14 18.31
Oct 39.26 36.46 41.95 13.10
Nov 37.17 36.13 39.04 7.46
Dec 38.84 35.41 40.25 12.02

Castle Biosciences (CSTL) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 37.04 33.46 39.17 14.56
Feb 39.53 36.54 43.96 16.87
Mar 38.09 35.74 39.21 8.84
Apr 39.42 37.11 40.69 8.82
May 37.93 35.65 41.81 14.73
Jun 37.40 34.52 38.71 10.82
Jul 32.90 30.83 34.51 10.68
Aug 33.27 32.15 34.76 7.50
Sep 34.15 31.14 36.35 14.34
Oct 31.95 29.94 34.01 11.97
Nov 34.32 31.78 38.07 16.53
Dec 33.94 30.14 36.36 17.12

Castle Biosciences (CSTL) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 32.42 29.88 35.37 15.53
Feb 33.78 32.03 36.67 12.64
Mar 35.25 31.40 37.81 16.96
Apr 33.82 32.63 35.99 9.34
May 36.04 33.77 39.17 13.78
Jun 40.13 35.92 43.44 17.33
Jul 42.60 40.81 46.72 12.64
Aug 43.08 38.31 47.78 19.82
Sep 46.03 41.26 50.93 18.98
Oct 47.77 44.23 52.52 15.79
Nov 46.17 41.64 48.37 13.90
Dec 44.36 41.38 48.52 14.72

Castle Biosciences information and performance

Castle of Biological Sciences, Inc., a commercial stage dermatological cancer, develops and commercializes diagnostic and prognostic tests for cancers. Its flagship product is DecisionDx-Melanoma, a Multiple Gene Expression Profile (GEP) test for identifying Stage I and II patients at high risk of metastasis, based on biological information from 31 genes in their tumor tissue. The company also offers the DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis in patients with uveal melanoma, a rare eye cancer; and two late-stage proprietary products that address squamous cell skin cancer and suspicious pigmented lesions, which are highly clinical indications for dermatological cancer. It offers testing services through physicians, physician assistants and nurse practitioners. The company was founded in 2007 and is headquartered in Friendswood, Texas.

Castle Biosciences Address

820 S FRIENDSWOOD DRIVE, SUITE 201, FRIENDSWOOD, TX, US

Market Capitalization: 601 937 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -80 599 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.59

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.926
Quarterly Revenue Growth YOY: 0.531
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.251

Enterprise Value (EV) /Revenue

EV To EBITDA: -7.4

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 26575600

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.